Chronic lung disease and the perception of breathlessness: clinical perspective.
Teramoto
S
S
D004417:Dyspnea / Q000503:physiopathology* / Q000517:prevention & control; D017079:Exercise Tolerance / Q000502:physiology; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000503:physiopathology*; D010276:Parasympatholytics / Q000627:therapeutic use; D010465:Perception / Q000187:drug effects / Q000502:physiology*; D012602:Scopolamine Derivatives / Q000627:therapeutic use
D010276:Parasympatholytics; D012602:Scopolamine Derivatives; C017590:oxitropium